MorphoSys AG (MPSYF)
USD 73.27
(0.0%)
USD 73.27
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -295.83 Million | -366.7 Million | -481.44 Million | 35.26 Million | -80.13 Million | -33.26 Million |
| Net Income | -189.73 Million | -151.05 Million | -514.46 Million | 97.89 Million | -103.01 Million | -56.17 Million |
| Depreciation & Amortization | 10.53 Million | 10.53 Million | 10.09 Million | 8.32 Million | 6.24 Million | 3.75 Million |
| Deferred income taxes | -1.18 Million | 168.57 Million | -76.59 Million | -75.39 Million | -3.5 Million | -4.3 Million |
| Stock-based compensation | 27.37 Million | 3.63 Million | 2.58 Million | 8.95 Million | 6.65 Million | 5.58 Million |
| Change in working capital | 7.21 Million | -51.43 Million | -112.99 Million | 12.83 Million | 17.83 Million | -4.5 Million |
| Other non-cash items | -150.03 Million | -346.96 Million | 209.92 Million | -17.33 Million | -4.35 Million | 22.37 Million |
| Investing Cash Flow | 15.37 Million | 345 Million | -831.01 Million | -879.62 Million | 78.55 Million | -177.26 Million |
| Investments in PPE | -2.87 Million | -15.22 Million | -26.15 Million | -49.33 Million | -3.66 Million | -2.46 Million |
| Acquisitions | 4.57 Million | - | -1.2 Billion | 2.47 Million | 562.31 Thousand | 644.57 Thousand |
| Investment purchases | -3.15 Billion | -1.88 Billion | -2.19 Billion | -1.74 Billion | -289.77 Million | -451.33 Million |
| Sales/Maturities of investments | 3.14 Billion | 2.24 Billion | 2.59 Billion | 915.58 Million | 371.87 Million | 276.36 Million |
| Other Investing Activities | 18.22 Million | 4.22 Million | 1.61 Million | 1.21 Million | -451.68 Thousand | -480 Thousand |
| Financing Cash Flow | 42.99 Million | 311.41 Million | 1.32 Billion | 907.18 Million | 353.23 Thousand | 179.46 Million |
| Debt repayment | -48.82 Million | -3.41 Million | -3.12 Million | -2.78 Million | -2.34 Million | -1.02 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 102.69 Million | 295.42 Million | 1.29 Billion | 80.59 Million | - | 193.61 Million |
| Other Financing Activities | -10.86 Million | 19.4 Million | 34.61 Million | 829.37 Million | 2.7 Million | -14.15 Million |
| Accounts receivables | 56.87 Million | -18.16 Million | 10.53 Million | -69.61 Million | 2.66 Million | -6.61 Million |
| Accounts payables | -44.27 Million | -21.09 Million | -90.81 Million | 77.5 Million | 13.2 Million | 1.89 Million |
| Inventory | 44.27 Million | - | -30.34 Million | -8.48 Million | -4.1 Million | 545.81 Thousand |
| Other working capital | -49.66 Million | -12.17 Million | -2.36 Million | 13.43 Million | 6.06 Million | 2.1 Million |
| Cash at beginning of period | 402.35 Million | 123.24 Million | 109.79 Million | 44.31 Million | 45.45 Million | 76.58 Million |
| Cash at end of period | 158.49 Million | 402.35 Million | 123.24 Million | 109.79 Million | 44.31 Million | 45.45 Million |
| Capital Expenditure | -2.87 Million | -15.22 Million | -26.15 Million | -49.33 Million | -3.66 Million | -2.46 Million |
| Effect of forex changes on cash | -6.38 Million | -10.61 Million | 2.98 Million | 3.39 Million | 87.11 Thousand | -59.46 Thousand |
| Net cash flow / Change in cash | -243.85 Million | 279.1 Million | 13.45 Million | 65.48 Million | -1.14 Million | -31.12 Million |
| Free Cash Flow | -298.7 Million | -381.93 Million | -507.6 Million | -14.06 Million | -83.8 Million | -35.73 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -311.04 Million | 48.26 Million | -189.73 Million | -119.6 Million | -73.96 Million | -44.43 Million |
| Depreciation & Amortization | 1.04 Million | 2.05 Million | 10.53 Million | 2.73 Million | 2.97 Million | 2.76 Million |
| Deferred income taxes | - | 275.46 Thousand | -1.18 Million | 19.85 Million | - | - |
| Stock-based compensation | 114.86 Million | 10.47 Million | 27.37 Million | 4.09 Million | 10.83 Million | 1.96 Million |
| Change in working capital | 103.14 Million | 19.49 Million | 7.21 Million | 37.76 Million | -63.72 Million | 13.67 Million |
| Other non-cash items | 40 Million | -124.42 Million | -150.03 Million | 21.47 Million | -2.09 Million | -45.2 Million |
| Investing Cash Flow | 36.24 Million | -61.59 Million | 15.37 Million | 34.9 Million | 23.24 Million | 9.88 Million |
| Investments in PPE | -48.19 Thousand | -690.97 Thousand | -2.87 Million | -1.65 Million | -102.09 Thousand | -424.12 Thousand |
| Acquisitions | 83.3 Thousand | - | 4.57 Million | - | 138.83 Thousand | - |
| Investment purchases | -360.18 Million | 2.76 Billion | -3.15 Billion | -743.38 Million | -778.9 Million | -1.24 Billion |
| Sales/Maturities of investments | 385.54 Million | -2.81 Billion | 3.14 Billion | 780 Million | 794.33 Million | 1.24 Billion |
| Other Investing Activities | 10.84 Million | -13.22 Million | 18.22 Million | -51.31 Thousand | 7.77 Million | 5.3 Million |
| Financing Cash Flow | -942.47 Thousand | 95.03 Million | 42.99 Million | -1.71 Million | -4.67 Million | -45.32 Million |
| Debt repayment | -942.47 Thousand | -1.01 Million | -48.82 Million | -2.42 Million | -2.53 Million | -43.68 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 96.04 Million | 102.69 Million | - | - | - |
| Other Financing Activities | -7815.00 | 94.21 Million | -10.86 Million | 2.26 Million | -2.13 Million | -1.63 Million |
| Accounts receivables | -717.43 Thousand | 9.33 Million | 56.87 Million | 27.9 Million | -8.55 Million | 28.18 Million |
| Accounts payables | 105.21 Million | -7.24 Million | -44.27 Million | 1.51 Million | -28.22 Million | -10.31 Million |
| Inventory | - | - | 44.27 Million | - | 28.22 Million | - |
| Other working capital | -1.35 Million | 17.4 Million | -49.66 Million | 8.35 Million | -55.16 Million | -4.19 Million |
| Cash at beginning of period | 158.49 Million | 187.83 Million | 402.35 Million | 184.32 Million | 291.74 Million | 402.35 Million |
| Cash at end of period | 131.25 Million | 158.49 Million | 158.49 Million | 187.83 Million | 184.32 Million | 291.74 Million |
| Capital Expenditure | -48.19 Thousand | -690.97 Thousand | -2.87 Million | -1.65 Million | -102.09 Thousand | -424.12 Thousand |
| Effect of forex changes on cash | 1.88 Million | -6.42 Million | -6.38 Million | 3.98 Million | -26.91 Thousand | -3.92 Million |
| Net cash flow / Change in cash | -27.24 Million | -29.33 Million | -243.85 Million | 3.5 Million | -107.42 Million | -110.6 Million |
| Free Cash Flow | -64.47 Million | -57.04 Million | -298.7 Million | -35.33 Million | -126.06 Million | -71.65 Million |
0HFB
ABAT
7864
600664
UPR
GENSOL